These analyses suggested that tumor cells might promote differentiation of CD34+ Fbs into APOE+ Fbs and MMP3+ Fbs in D‐TGCT, turning “mild” fibroblast clusters into “aggressive” ones. The gene discussed is CD34; the disease is neoplasm.